跳到正文

药物警戒与上市后安全监测

结合 FAERS、FDA 标签和文献整理药物安全信号,记录报告比例与证据限制,供药物警戒人员复核。

开源精选医疗业务10 个文件1,738 Stars浏览次数 0mims-harvard/ToolUniverse Apache-2.0版本 8c6ed47
开始使用

下载前阅读 SKILL.md 中的使用条件,并确认所用工具支持对应能力。

输入资料
药物名称、事件与研究范围 ToolUniverse 环境及数据库访问条件 阅读本节完整说明
交付内容
有来源的安全信号报告 检索、统计与限制记录 阅读本节完整说明
  1. 获取完整包,保留配套文件的目录结构。
  2. 按照原文准备所需工具、依赖与输入资料。
  3. 阅读对应使用步骤与输入输出说明,在自己的环境中验证结果。

使用提示摘自原文,配套文件保留来源版本;实际运行条件以各包说明为准。

正文

获取原文件

SIGNAL_DETECTION.md

Detailed methodology for pharmacovigilance signal detection, disproportionality analysis, and signal prioritization.


Disproportionality Analysis

Proportional Reporting Ratio (PRR):

PRR = (A/B) / (C/D)

Where:
A = Reports of drug X with event Y
B = Reports of drug X with any event
C = Reports of event Y with any drug (excluding X)
D = Total reports (excluding drug X)

Signal Thresholds:

Measure Signal Threshold Strong Signal
PRR >2.0 >3.0
Chi-squared >4.0 >10.0
N (case count) >=3 >=10

Severity Classification

Category Definition Priority
Fatal Death outcome Highest
Life-threatening Immediate death risk Very High
Hospitalization Required/prolonged hospitalization High
Disability Persistent impairment High
Congenital anomaly Birth defect High
Other serious Medical intervention required Medium
Non-serious No serious criteria Low

Signal Scoring Formula

Signal Score = PRR x Severity_Weight x log10(Case_Count + 1)

Severity Weights:
- Fatal: 10
- Life-threatening: 8
- Hospitalization: 5
- Disability: 5
- Other serious: 3
- Non-serious: 1

Evidence Grading

Tier Symbol Criteria Example
T1 Critical PRR >10, fatal outcomes, boxed warning Lactic acidosis
T2 Serious PRR 3-10, serious outcomes Hepatotoxicity
T3 Moderate PRR 2-3, moderate concern Hypoglycemia
T4 Low PRR <2, known/expected GI side effects

Warning Severity Categories (Label)

Category Description
Boxed Warning Most serious, life-threatening
Contraindication Must not use
Warning Significant risk
Precaution Use caution

PGx Evidence Levels

Level Description Clinical Action
1A CPIC/DPWG guideline, implementable Follow guideline
1B CPIC/DPWG guideline, annotation Consider testing
2A VIP annotation, moderate evidence May inform
2B VIP annotation, weaker evidence Research
3 Low-level annotation Not actionable

Example: FAERS Signal Interpretation

Strong Signal: Lactic Acidosis

  • PRR of 15.2 indicates 15x higher reporting rate than expected
  • 89% classified as serious
  • 156 fatalities (12.5% case fatality)
  • Known class effect of biguanides
  • Risk factors: renal impairment, hypoxia, contrast agents

Moderate Signal: Hepatotoxicity

  • PRR of 3.1, 234 serious reports, 12 fatal
  • Check LFTs if symptoms

Known/Expected: GI Effects

  • Diarrhea PRR 2.3, 18% frequency -> Start low, titrate slow
  • Nausea PRR 1.8, 12% frequency -> Take with food

CONTACT HAONAN

联系haonan

医疗 AI · 产品与独立开发

刘浩南

关注医疗 AI 从 demo 到真实落地,聚焦产品化、商业化与院内工作流效率提升。

12年医疗产研经验,大湾区头部医疗AI公司前产品总监,独立开发者

医疗 AI 产品化医疗 AI 商业化院内工作流效率
刘浩南的微信联系二维码
微信扫一扫,联系 haonan